- cafead   Mar 27, 2023 at 10:12: PM
via After much talk about reforming its accelerated approval pathway, the Food and Drug Administration has taken a small step toward that goal. To “reduce clinical uncertainty,” the agency has proposed new guidelines for cancer drug developers that would tighten up requirements for clinical trials.
article source
article source